The purpose of this investigation was to develop a system for studying the effects of dopamine on isolated blood vessels. Canine renal, mesenteric, and small femoral arteries (less than 1 mm outside diameter) were exposed to phenoxybenzamine 1O~5 M for one hour and contracted with prostaglandin F 2a . Cumulative concentrations of dopamine ranging from 10" 6 to lO" 4 M caused dose-related relaxation of the arteries. Propranolol 10~6 M did not affect the relaxation in concentrations which markedly antagonized the effects of isoproterenol. Large femoral arteries (greater than 1 mm outside diameter) did not relax with similar concentrations of dopamine. N-methyldopamine (epinine) produced similar relaxation; 3-methoxytyramine was inactive. Specific antagonism could not be demonstrated by the postulated dopamine antagonists-haloperidol. chlorpromazine, apomorphine, or bulbocapnine-in concentrations up to 10" 5 M. Higher concentration of these agents could not be used because they caused the arteries to relax. This study demonstrated that PGF^-contracted arteries pretreated with phenoxybenzamine are suitable for further investigations of putative dopamine agonists and antagonists.
• Studies in the intact dog have shown that dopamine increases renal and mesenteric blood flow by an unusual mechanism. 1 Characterization of the vasodilation as dopamine-like is based on three sets of findings:
1. The vasodilation is selective. Similar vasodilation does not occur in the femoral vascular bed of the anesthetized dog.
2. The chemical structural requirements for dopamine-induced vasodilation are extraordinarily specific. The only phenylethylamine found to exert similar effects is the n-methyl derivative of dopamine, epinine. 2 Apomorphine, which is structurally related to dopamine, exerts a weak dopaminergic action. 2 More recently, an apomorphine derivative, 6-propyl-noraporphine-10,ll-diol, was found to exert activity greater than apomorphine but less than that of dopamine. 3 3. Dopamine-induced vasodilation is not blocked by propranolol, atropine, antihistamines, or other standard antagonists. In contrast, the vasodilation is attenuated by haloperidol, 4 phenothiazines, 5 and bulbocapnine. 6 Apomorphine is also a weak antagonist. 6 These studies strongly suggest that dopamine is acting on a specific receptor. Precise quantitation of agonist-antagonist relationships, however, requires demonstration of similar effects in an isolated organ system. 7 Previous attempts to characterize a relaxing action of dopamine in isolated blood vessels have not been successful. Strandhoy et al. 8 and Kelly, 9 utilizing uncontracted isolated canine renal artery preparations, and Browne and Zaroslinski, 10 using a rat renal artery, reported that dopamine caused typical alpha adrenergic contraction of these preparations. In contrast, Burn and Rand" reported that extremely high concentrations of dopamine relaxed norepinephrine-contracted rabbit aortic strips, and Patil et al. 12 and Kohli 13 described apparently similar relaxation when the same preparation was treated with alpha adrenergic blocking agents and contracted with histamine or carbachol. The latter investigator also reported that the relaxation was reversed by propranolol, suggesting a possible beta adrenergic mechanism.
In order to evaluate these apparently contradictory results, we studied the effects of dopamine in canine renal, mesenteric, and femoral artery strips contracted with potassium. Preliminary studies indicated that after application of high concentrations of phenoxybenzamine (POB), dopamine caused dose-related relaxation without contraction in many but not all preparations. M - 15 However, the I 98 GOLDBERG. TODA inability to demonstrate relaxation in the potassium-contracted artery consistently prevented quantitative characterization of the phenomenon. In the present study isolated arteries treated with POB and contracted with prostaglandin F 2a consistently relaxed when dopamine was applied. This innovation made it possible to determine the effects of beta adrenergic and potential dopamine antagonists and to compare the actions of dopamine with structurally related sympathomimetic amines. Interest in characterizing the putative dopamine receptor was intensified by recent studies suggesting that dopamine may be involved in the physiological maintenance of plasma volume and blood pressure. 16 
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Methods
Mongrel dogs of either sex were anesthetized with intraperitoneal injections of pentobarbital sodium in a dose of 50 mg/kg and sacrificed by bleeding from the common carotid artery. Branches of the superior mesenteric, renal, and femoral arteries were dissected free and resected in a nutrient solution. The vessels were either used immediately or after storage at a temperature of 4°C for a maximum period of 48 hours. The outside diameter of the arteries ranged from 0.5 to 2 mm. Arteries less than 1 mm outside diameter were arbitrarily called "small." Those greater than 1 mm were called "large." The isolated arteries were cut into helical strips of approximately 25 mm in length. The vascular strips were fixed vertically between hooks under resting tension of 1.5 g for small arteries and 2 g for large arteries in a muscle bath of 20-ml capacity containing the nutrient solution. The upper end of the strips was connected to the lever of a force-displacement transducer.* The bathing medium was maintained at 37 ± 0.5°C and was gassed with a mixture of 95% O 2 and 5% CO 2 . The composition of the solution was as follows (HIM): Na + 162.1, K + 5.4, Ca ++ 2.2, Cl" 157.0, HCO 3 -14.9, dextrose 5.6.
The pH of the solution was 7.2 to 7.4. Before an experiment was commenced, the preparation was allowed to equilibrate for 90 to 120 minutes in the bathing medium; during the equilibration period the medium was replaced repeatedly at intervals of 20 to 30 minutes.
The arterial strips were contracted by adding prostaglandin F 2o (3 x 10' 7 to 3 x 10" 6 M). Cumulative dose-response curves with dopamine, isoproterenol, epinine, or 3-methoxytyramine were then obtained. When the dose-response curve was completed, the bathing fluid was removed, and the preparation was washed at least three times with fresh solution before again adding an agonist alone or an agonist and an antagonist. Propranolol, bulbocapnine, haloperidol, apomorphine, or chlorpromazine was added to the bathing fluid 30 to 40 minutes before the agonists were applied. POB was left in contact with the strips for 30 to 60 minutes, after which the bathing fluid was changed and the strips were washed in fresh solution. Results shown in the figures * Nihonkoden Kogyo Co., Tokyo, Japan. and in the text are expressed as mean ± standard error of the mean. Comparisons of the results were made by Student's paired t-test.
Materials used were as follows: dopamine HC1 (Calbiochem); epinine HC1 (Abbott Laboratories); 3-methoxytyramine (Sigma); chlorpromazine HC1 (Takeda); phenoxybenzamine (Dibenzyline, Smith, Kline & French); d,/-propranolol HC1 (Inderal, Sumitomo); bulbocapnine (Pennick Laboratories); apomorphine HCL (Lilly); haloperidol (Haldol, McNeil Laboratories); prostaglandin F 2o (Ono Pharmaceutical Co.); d-l, isoproterenol (Sumitomo). Sodium metabisulfite (0.1%) was added to all catecholamine solutions to prevent oxidation.
Results
EFFECTS OF PGF*,
PGF 2(> caused dose-related contractions in renal, mesenteric, and femoral arteries in concentrations ranging from 10~7 to 10~6 M. Kadar and Sunahara 19 had previously reported that PGF 2a caused contractions of isolated canine mesenteric arteries, and Strong and Bohr 20 described contractions of canine renal, mesenteric, and skeletal muscle arteries with the related PGF, Q . In most experiments stable contractions at the desired tension could be attained with PGF 2o within 60 to 90 minutes. Greater increase in tension could be rapidly achieved by increasing the concentration of PGF 2a . Tachyphylaxis was not observed. The only difficulty noted was the occurrence of spontaneous movements which could be eliminated by washing the preparation with nutrient fluid and contracting the strips a second time with a lower concentration of PGF 2a .
EFFECTS OF DOPAMINE
After administration of POB 10 ~6 M for one hour, dose-related relaxation was consistently observed with concentrations of dopamine ranging from 10" 6 to 10" 4 M ( Fig. 1 , Table 1 ). In contrast to the experiments in which the strips were contracted with potassium, contractions were not observed in any of these experiments. There was no detectable difference in the actions of dopamine in small and large renal and mesenteric arteries. As shown in Table 1 , approximately equal relaxation occurred with two successive administrations of dopamine.
Dopamine caused relaxation in small femoral arteries contracted with PGF 2a similar to that in the renal and mesenteric arteries. In contrast, previous studies with K + -contracted strips 14 ' 15 indicated that dopamine was less effective in small femoral arteries than in renal or mesenteric arteries.
Relaxation was not observed with concentrations of dopamine less than 10~4 M in 12 large femoral arteries, and the average response in these vessels was contraction (Table 1 ). In two preparations pronounced relaxation was observed with concentrations of dopamine of IO" 4 M. The intensity of the relaxation and its occurrence with only one concentration of dopamine suggested that the mechanism of relaxation in these two preparations was different from that observed in the renal, mesenteric, and small femoral arteries. These results with the PGF 2a -contracted large femoral arteries were similar to those previously reported with K + contracted strips. 14 
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Papaverine 10" 4 M was administered in most experiments after completion of the dopamine dose-response curve. Papaverine caused further relaxation of preparations except those in which dopamine had already produced maximum relaxation. Since papaverine was as effective in large femoral arteries as in renal, mesenteric, and small femoral arteries, differences in the response of these preparations could not be explained by inability of the large femoral artery to relax.
EFFECTS OF PROPRANOLOL ON DOPAMINE AND ISOPROTERENOL-INDUCED RELAXATION
Effects of propranolol 10" 6 M on the relaxation produced by dopamine in ten mesenteric, ten renal, and ten small femoral arteries were investigated. As shown in Table 1 and Figure 1 , the addition of propranolol had no effect on the relaxation produced by dopamine in these vessels. As expected, the relaxation produced by isoproterenol in eight mesenteric arteries was shifted markedly to the right by this concentration of propranolol (Fig. 2) .
INVESTIGATION OF POTENTIAL DOPAMINE ANTAGONISTS
The effects of apomorphine, bulbocapnine, haloperidol, and chlorpromazine were investigated in several renal and mesenteric arteries contracted with potassium and PGF 2a . Each of these agents caused profound relaxation of the PGF 2a -contracted arterial strips when concentrations greater than 1O~5 M were added to the bath. When concentrations of 10" 5 M or lower were studied, there was no effect on dopamine-induced relaxation.
INVESTIGATION OF OTHER AMINES
The effects of epinine were investigated in mesenteric and large femoral arterial strips. As shown in Table 2 , the effects of epinine were similar to those produced by dopamine. Also, as with dopamine, propranolol did not attenuate epinineinduced relaxation. In contrast, the dopamine metabolite, 3-methoxytyramine, did not cause relaxation in mesenteric vessels which were responsive to dopamine (Table 3 ).
Discussion
The primary objective of this study was to determine whether dopamine could cause relaxation of isolated arteries. Since both vasoconstriction and vasodilation are produced by the amine in intact animals, it was essential to devise an in vitro Antagonism by propranolol (70" s M for 30 minutes) of isoproterenol-induced relaxation in mesenteric arteries contracted with PGF^. The arteries were also exposed to POB IO~' M for an hour. The mean tension produced by PGF%, was 900 ± 0.13 before propranolol and 880 ± 0.12 mg after propranolol.
technique which would separate these opposing actions. Canine renal and mesenteric arteries were chosen because dopamine causes vasodilation in renal and mesenteric vascular beds in doses lower than those producing vasoconstriction. 1 The responses, however, were found to be uniformly reversed in untreated isolated arteries and in those partially contracted with potassium or PGF 2a . Thus, relaxation was not observed unless the vessels were previously exposed to high concentrations of POB. The variations in the action of dopamine in vivo and in vitro probably do not represent a fundamental difference in drug action for similar reversals of response have been reported with other amines exhibiting vasoconstricting and vasodilating properties. As Bohr et al. 21 pointed out, arteries in vivo are in a state of partial contraction and can dilate, whereas isolated arteries bathed in nutrient solution often are maximally relaxed. Lack of tone may explain why previous investigators could not demonstrate dopamineinduced relaxation in isolated canine arteries. In our preliminary experiments potassium was used as the contracting agent because it causes long-lasting stable contractions in all types of arteries and tachyphylaxis does not occur. Although dose-related relaxation was observed when dopamine was applied to the potassium-contracted artery treated with a very high concentration of phenoxybenzamine (10~5 M for one hour), it was not possible to eliminate dopamine-induced contractions in all experiments. In addition, the magnitude of dopamine-induced relaxation was less in the potassium-contracted strip, 14 ' 15 apparently because of residual opposing contracting actions. Fortunately, it was possible to eliminate dopamine-induced contractions in the PGF 2(l treated artery. The mechanism responsible for the difference in response of the strips with the two contracting agents was not determined in these studies.
HYPERTENSION XXIII
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The present results definitively demonstrate that effective antagonistic concentrations of propranolol do not affect dopamine-induced relaxation. These results are consistent with previous investigations which demonstrated that dopamine has extremely weak or no action on peripheral beta adrenergic receptors. 22 -' Studies in this laboratory have also shown that dopamine-induced relaxation in iso-lated canine coronary arteries is not attenuated by propranolol. 23 These results are in apparent conflict with experiments with high concentrations of dopamine in the isolated rabbit aortic strip 13 and the intact dog. 24 In both of these preparations propranolol reversed the effects of dopamine. However, in addition to a possible action on beta adrenergic receptors, this reversal could have been the result of attenuation of the action of phenoxybenzamine by propranolol and re-emergence of the vasoconstriction produced by the high concentration of dopamine. 13 ' 26 Although the present results did not demonstrate specific antagonism of the putative dopamine receptor, the method described should be applicable for separating the actions of dopamine-like compounds from nonspecific relaxing agents and beta adrenergic agonists. By use of a responsive vessel such as a renal or mesenteric artery and a nonresponsive large femoral artery, preliminary separation of dopamine-like compounds from nonspecific vasodilating agents should be possible. In this way epinine would be considered dopamine-like and 3methoxytyramine inactive. The fact that a similar conclusion was reached in studies in the intact dog is strong supporting evidence that the actions of 
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GOLDBERG. TODA dopamine in vivo and in vitro are due to the same mechanism: action on a specific dopamine receptor.
